Bulletin
Investor Alert

Century Therapeutics Inc.

NAS: IPSC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 24, 2022, 4:01 p.m.

/zigman2/quotes/210490648/composite

$

13.89

Change

0.00 0.00%

Volume

Volume 1,340

Quotes are delayed by 20 min

/zigman2/quotes/210490648/composite

Previous close

$ 13.20

$ 13.89

Change

+0.69 +5.23%

Day low

Day high

$12.56

$14.12

Open

52 week low

52 week high

$12.47

$32.90

Open

Annual Financials for Century Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20192020 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A ---249,0001.4M
COGS excluding D&A -----
Depreciation & Amortization Expense ---249,0001.4M
Depreciation ---249,0001.4M
Amortization of Intangibles -----
Gross Income ---(249,000)(1.4M)
20192020 5-year trend
SG&A Expense ---19.78M47.77M
Research & Development ---14.27M39.68M
Other SG&A ---5.52M8.09M
Other Operating Expense -----
Unusual Expense ---225.95M4.72M
EBIT after Unusual Expense ---(245.98M)(53.9M)
Non Operating Income/Expense ---1.21M704,000
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense ----381,000
Gross Interest Expense ----381,000
Interest Capitalized -----
Pretax Income ---(244.77M)(53.58M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income ---(244.77M)(53.58M)
Minority Interest Expense -----
Net Income ---(244.77M)(53.58M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries ---(244.77M)(53.58M)
Preferred Dividends -----
Net Income Available to Common ---(244.77M)(53.58M)
EPS (Basic) -----
Basic Shares Outstanding -----
EPS (Diluted) -----
Diluted Shares Outstanding -----
EBITDA ---(19.78M)(47.77M)
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.